Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab.
Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab. Cell Cycle. 2011 Jul 15; 10(14):2331-8.